The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells

Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies

(2012) Rotem Ben-Hamo et al.   BMC Systems Biology

Triphenylmethyl Derivatives Enhances the Anticancer Effect of Immunotoxins

(2011) Karianne Risberg et al.   JOURNAL OF IMMUNOTHERAPY

KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma

(2011) T Jiffar et al.   ONCOGENE

Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis

(2011) Catherine Emmanuel et al.   PLoS One

Protein kinase C regulates mitochondrial targeting of Nur77 and its family member Nor-1 in thymocytes undergoing apoptosis

(2010) Jennifer Thompson et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Anti-Melanoma Activity of the 9.2.27PE Immunotoxin in Dacarbazine Resistant Cells

(2010) Karianne Risberg et al.   JOURNAL OF IMMUNOTHERAPY

Minireview: Nuclear Hormone Receptor 4A Signaling: Implications for Metabolic Disease

(2010) Michael A. Pearen et al.   MOLECULAR ENDOCRINOLOGY

Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo

(2009) Y Andersson et al.   BRITISH JOURNAL OF CANCER

Thrombospondins: from structure to therapeutics

(2008) S. Kazerounian et al.   CELLULAR AND MOLECULAR LIFE SCIENCES